Showing results (1441-1450 of 2,335) with videos related to

Sort By:
Pageof 234
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.
Scientific Reports|March 6, 2020
High-Throughput Screening to Predict Chemical-Assay InterferenceAlexandre Borrel, Ruili Huang, Srilatha Sakamuru, et al.
The New England Journal of Medicine|October 23, 1986
Interferon therapy for condylomata acuminataL J Eron, F Judson, S Tucker, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|June 29, 2019
Pressure cycling technology for challenging proteomic sample processing: application to barnacle adhesiveJanna N Schultzhaus, Scott N Dean, Dagmar H Leary, et al.
Medrxiv : the Preprint Server for Health Sciences|April 17, 2023
A signature of pre-operative biomarkers of cellular senescence to predict risk of cardiac and kidney adverse events after cardiac surgeryAmy Entwistle, Susan Walker, Anne Knecht, et al.
ESC Heart Failure|March 31, 2021
Outflow graft obstruction after left ventricular assist device implantation: a retrospective, single-centre case seriesAkanksha Agrawal, Tamas Alexy, Norihiko Kamioka, et al.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2020
Selecting a minimal set of androgen receptor assays for screening chemicalsRichard Judson, Keith Houck, Katie Paul Friedman, et al.
Chemical Research in Toxicology|February 21, 2015
Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structureJie Liu, Kamel Mansouri, Richard S Judson, et al.
American Heart Journal Plus : Cardiology Research and Practice|October 27, 2023
Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarctionGregory L Judson, Beth E Cohen, Anoop Muniyappa, et al.
Oral Oncology|June 11, 2019
Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatmentLiliya Benchetrit, Sina J Torabi, Janet P Tate, et al.
Pageof 234